Abstract
Summary
Atracurium besylate is a drug with the trade name carcinogen. It is a commonly used muscle relaxant and is a medium-lasting muscle relaxant. It is commonly used for skeletal muscle relaxation during general anesthesia in various surgeries, or for muscle relaxation required during tracheal intubation. In addition, atracurium besylate can also be used for sedation in intensive care patients.
Atracurium besylate is hydrolyzed by esterase in the body to produce free atracurium, which is further hydrolyzed by pseudocholinesterase in the blood to produce acetate and quaternary ammonium salts. This double hydrolysis process accelerates the metabolism of atracurium, causing it to remain active in the body for a shorter period of time.
It should be noted that atracurium can induce histamine release, and some patients may experience severe hypotension. Additionally, atracurium may be used for sedation in intensive care patients and may therefore be limited in patients requiring respiratory support.
The global market for Atracurium Besylate was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atracurium Besylate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Atracurium Besylate by region & country, by Type, and by Application.
The Atracurium Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atracurium Besylate.
Market Segmentation
By Company
Abbott
Med Chem Express
Sagent Pharma
Meitheal Pharma
Pfizer
Selleck Chemicals
Merck
Jiangsu Hengrui Medicine Co., Ltd
AdooQ
Segment by Type:
API
Injection
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Atracurium Besylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Atracurium Besylate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Atracurium Besylate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Atracurium besylate is hydrolyzed by esterase in the body to produce free atracurium, which is further hydrolyzed by pseudocholinesterase in the blood to produce acetate and quaternary ammonium salts. This double hydrolysis process accelerates the metabolism of atracurium, causing it to remain active in the body for a shorter period of time.
It should be noted that atracurium can induce histamine release, and some patients may experience severe hypotension. Additionally, atracurium may be used for sedation in intensive care patients and may therefore be limited in patients requiring respiratory support.
The global market for Atracurium Besylate was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atracurium Besylate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Atracurium Besylate by region & country, by Type, and by Application.
The Atracurium Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atracurium Besylate.
Market Segmentation
By Company
Abbott
Med Chem Express
Sagent Pharma
Meitheal Pharma
Pfizer
Selleck Chemicals
Merck
Jiangsu Hengrui Medicine Co., Ltd
AdooQ
Segment by Type:
API
Injection
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Atracurium Besylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Atracurium Besylate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Atracurium Besylate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Atracurium Besylate Product Introduction
1.2 Global Atracurium Besylate Market Size Forecast
1.2.1 Global Atracurium Besylate Sales Value (2019-2030)
1.2.2 Global Atracurium Besylate Sales Volume (2019-2030)
1.2.3 Global Atracurium Besylate Sales Price (2019-2030)
1.3 Atracurium Besylate Market Trends & Drivers
1.3.1 Atracurium Besylate Industry Trends
1.3.2 Atracurium Besylate Market Drivers & Opportunity
1.3.3 Atracurium Besylate Market Challenges
1.3.4 Atracurium Besylate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Atracurium Besylate Players Revenue Ranking (2023)
2.2 Global Atracurium Besylate Revenue by Company (2019-2024)
2.3 Global Atracurium Besylate Players Sales Volume Ranking (2023)
2.4 Global Atracurium Besylate Sales Volume by Company Players (2019-2024)
2.5 Global Atracurium Besylate Average Price by Company (2019-2024)
2.6 Key Manufacturers Atracurium Besylate Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Atracurium Besylate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Atracurium Besylate
2.9 Atracurium Besylate Market Competitive Analysis
2.9.1 Atracurium Besylate Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Atracurium Besylate Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atracurium Besylate as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 API
3.1.2 Injection
3.2 Global Atracurium Besylate Sales Value by Type
3.2.1 Global Atracurium Besylate Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Atracurium Besylate Sales Value, by Type (2019-2030)
3.2.3 Global Atracurium Besylate Sales Value, by Type (%) (2019-2030)
3.3 Global Atracurium Besylate Sales Volume by Type
3.3.1 Global Atracurium Besylate Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Atracurium Besylate Sales Volume, by Type (2019-2030)
3.3.3 Global Atracurium Besylate Sales Volume, by Type (%) (2019-2030)
3.4 Global Atracurium Besylate Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Atracurium Besylate Sales Value by Application
4.2.1 Global Atracurium Besylate Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Atracurium Besylate Sales Value, by Application (2019-2030)
4.2.3 Global Atracurium Besylate Sales Value, by Application (%) (2019-2030)
4.3 Global Atracurium Besylate Sales Volume by Application
4.3.1 Global Atracurium Besylate Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Atracurium Besylate Sales Volume, by Application (2019-2030)
4.3.3 Global Atracurium Besylate Sales Volume, by Application (%) (2019-2030)
4.4 Global Atracurium Besylate Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Atracurium Besylate Sales Value by Region
5.1.1 Global Atracurium Besylate Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Atracurium Besylate Sales Value by Region (2019-2024)
5.1.3 Global Atracurium Besylate Sales Value by Region (2025-2030)
5.1.4 Global Atracurium Besylate Sales Value by Region (%), (2019-2030)
5.2 Global Atracurium Besylate Sales Volume by Region
5.2.1 Global Atracurium Besylate Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Atracurium Besylate Sales Volume by Region (2019-2024)
5.2.3 Global Atracurium Besylate Sales Volume by Region (2025-2030)
5.2.4 Global Atracurium Besylate Sales Volume by Region (%), (2019-2030)
5.3 Global Atracurium Besylate Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Atracurium Besylate Sales Value, 2019-2030
5.4.2 North America Atracurium Besylate Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Atracurium Besylate Sales Value, 2019-2030
5.5.2 Europe Atracurium Besylate Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Atracurium Besylate Sales Value, 2019-2030
5.6.2 Asia Pacific Atracurium Besylate Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Atracurium Besylate Sales Value, 2019-2030
5.7.2 South America Atracurium Besylate Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Atracurium Besylate Sales Value, 2019-2030
5.8.2 Middle East & Africa Atracurium Besylate Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Atracurium Besylate Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Atracurium Besylate Sales Value
6.2.1 Key Countries/Regions Atracurium Besylate Sales Value, 2019-2030
6.2.2 Key Countries/Regions Atracurium Besylate Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Atracurium Besylate Sales Value, 2019-2030
6.3.2 United States Atracurium Besylate Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Atracurium Besylate Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Atracurium Besylate Sales Value, 2019-2030
6.4.2 Europe Atracurium Besylate Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Atracurium Besylate Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Atracurium Besylate Sales Value, 2019-2030
6.5.2 China Atracurium Besylate Sales Value by Type (%), 2023 VS 2030
6.5.3 China Atracurium Besylate Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Atracurium Besylate Sales Value, 2019-2030
6.6.2 Japan Atracurium Besylate Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Atracurium Besylate Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Atracurium Besylate Sales Value, 2019-2030
6.7.2 South Korea Atracurium Besylate Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Atracurium Besylate Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Atracurium Besylate Sales Value, 2019-2030
6.8.2 Southeast Asia Atracurium Besylate Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Atracurium Besylate Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Atracurium Besylate Sales Value, 2019-2030
6.9.2 India Atracurium Besylate Sales Value by Type (%), 2023 VS 2030
6.9.3 India Atracurium Besylate Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Atracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Atracurium Besylate Product Offerings
7.1.5 Abbott Recent Development
7.2 Med Chem Express
7.2.1 Med Chem Express Company Information
7.2.2 Med Chem Express Introduction and Business Overview
7.2.3 Med Chem Express Atracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Med Chem Express Atracurium Besylate Product Offerings
7.2.5 Med Chem Express Recent Development
7.3 Sagent Pharma
7.3.1 Sagent Pharma Company Information
7.3.2 Sagent Pharma Introduction and Business Overview
7.3.3 Sagent Pharma Atracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sagent Pharma Atracurium Besylate Product Offerings
7.3.5 Sagent Pharma Recent Development
7.4 Meitheal Pharma
7.4.1 Meitheal Pharma Company Information
7.4.2 Meitheal Pharma Introduction and Business Overview
7.4.3 Meitheal Pharma Atracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Meitheal Pharma Atracurium Besylate Product Offerings
7.4.5 Meitheal Pharma Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Information
7.5.2 Pfizer Introduction and Business Overview
7.5.3 Pfizer Atracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Pfizer Atracurium Besylate Product Offerings
7.5.5 Pfizer Recent Development
7.6 Selleck Chemicals
7.6.1 Selleck Chemicals Company Information
7.6.2 Selleck Chemicals Introduction and Business Overview
7.6.3 Selleck Chemicals Atracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Selleck Chemicals Atracurium Besylate Product Offerings
7.6.5 Selleck Chemicals Recent Development
7.7 Merck
7.7.1 Merck Company Information
7.7.2 Merck Introduction and Business Overview
7.7.3 Merck Atracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Merck Atracurium Besylate Product Offerings
7.7.5 Merck Recent Development
7.8 Jiangsu Hengrui Medicine Co., Ltd
7.8.1 Jiangsu Hengrui Medicine Co., Ltd Company Information
7.8.2 Jiangsu Hengrui Medicine Co., Ltd Introduction and Business Overview
7.8.3 Jiangsu Hengrui Medicine Co., Ltd Atracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jiangsu Hengrui Medicine Co., Ltd Atracurium Besylate Product Offerings
7.8.5 Jiangsu Hengrui Medicine Co., Ltd Recent Development
7.9 AdooQ
7.9.1 AdooQ Company Information
7.9.2 AdooQ Introduction and Business Overview
7.9.3 AdooQ Atracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
7.9.4 AdooQ Atracurium Besylate Product Offerings
7.9.5 AdooQ Recent Development
8 Industry Chain Analysis
8.1 Atracurium Besylate Industrial Chain
8.2 Atracurium Besylate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Atracurium Besylate Sales Model
8.5.2 Sales Channel
8.5.3 Atracurium Besylate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer